Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Minimal disease activity (MDA) in patients with recent-onset psoriatic arthritis: predictive model based on machine learning.
Queiro R, Seoane-Mato D, Laiz A, Agirregoikoa EG, Montilla C, Park HS, Pinto-Tasende JA, Bethencourt Baute JJ, Ibáñez BJ, Toniolo E, Ramírez J, García AS; Proyecto REAPSER Study Group. Queiro R, et al. Among authors: montilla c. Arthritis Res Ther. 2022 Jun 24;24(1):153. doi: 10.1186/s13075-022-02838-2. Arthritis Res Ther. 2022. PMID: 35751091 Free PMC article.
First signs and symptoms of spondyloarthritis--data from an inception cohort with a disease course of two years or less (REGISPONSER-Early).
Rojas-Vargas M, Muñoz-Gomariz E, Escudero A, Font P, Zarco P, Almodovar R, Gratacós J, Mulero J, Juanola X, Montilla C, Moreno E, Collantes-Estevez E; Registro Español de Espondiloartritis de la Sociedad Española de Reumatología Working Group. Rojas-Vargas M, et al. Among authors: montilla c. Rheumatology (Oxford). 2009 Apr;48(4):404-9. doi: 10.1093/rheumatology/ken506. Epub 2009 Feb 10. Rheumatology (Oxford). 2009. PMID: 19208685 Free PMC article.
Risk variants for psoriasis vulgaris in a large case-control collection and association with clinical subphenotypes.
Julià A, Tortosa R, Hernanz JM, Cañete JD, Fonseca E, Ferrándiz C, Unamuno P, Puig L, Fernández-Sueiro JL, Sanmartí R, Rodríguez J, Gratacós J, Dauden E, Sánchez-Carazo JL, López-Estebaranz JL, Moreno-Ramírez D, Queiró R, Montilla C, Torre-Alonso JC, Pérez-Venegas JJ, Vanaclocha F, Herrera E, Muñoz-Fernández S, González C, Roig D, Erra A, Acosta I, Fernández-Nebro A, Zarco P, Alonso A, López-Lasanta M, García-Montero A, Gelpí JL, Absher D, Marsal S. Julià A, et al. Among authors: montilla c. Hum Mol Genet. 2012 Oct 15;21(20):4549-57. doi: 10.1093/hmg/dds295. Epub 2012 Jul 19. Hum Mol Genet. 2012. PMID: 22814393
Performance of the Assessment of Spondyloarthritis International Society criteria for the classification of spondyloarthritis in early spondyloarthritis clinics participating in the ESPERANZA programme.
Tomero E, Mulero J, de Miguel E, Fernández-Espartero C, Gobbo M, Descalzo MA, Collantes-Estévez E, Zarco P, Muñoz-Fernández S, Carmona L; ESPERANZA Study Group. Tomero E, et al. Rheumatology (Oxford). 2014 Feb;53(2):353-60. doi: 10.1093/rheumatology/ket359. Epub 2013 Nov 5. Rheumatology (Oxford). 2014. PMID: 24196385
Recommendations for the coordinated management of psoriatic arthritis by rheumatologists and dermatologists: a Delphi study.
Cañete JD, Daudén E, Queiro R, Aguilar MD, Sánchez-Carazo JL, Carrascosa JM, Carretero G, García-Vivar ML, Lázaro P, López-Estebaranz JL, Montilla C, Ramírez J, Rodríguez-Moreno J, Puig L. Cañete JD, et al. Among authors: montilla c. Actas Dermosifiliogr. 2014 Apr;105(3):216-32. doi: 10.1016/j.adengl.2013.07.003. Epub 2014 Mar 20. Actas Dermosifiliogr. 2014. PMID: 24657018 Free article.
Ankylosing spondylitis without axial progression: analysis of associated factors.
Montilla C, Díaz-Alvarez A, Calero-Paniagua I, Collantes-Estevez E, Font P, Almodovar R, Zarco P, Queiro-Silva R, Cañete JD, Juanola X, Mulero J, de Miguel E, Gratacós J; REGISPONSER Study Group. Montilla C, et al. J Rheumatol. 2014 Dec;41(12):2409-12. doi: 10.3899/jrheum.140018. Epub 2014 Nov 1. J Rheumatol. 2014. PMID: 25362657
PDE3A-SLCO1C1 locus is associated with response to anti-tumor necrosis factor therapy in psoriatic arthritis.
Julià A, Rodríguez J, Fernández-Sueiro JL, Gratacós J, Queiró R, Montilla C, Torre-Alonso JC, Pérez-Venegas JJ, Manrique-Arija S, Muñoz-Fernández S, González C, Roig D, Zarco P, Erra A, Castañeda S, García A, Salvador G, Díaz-Torne C, Blanco R, Domínguez AW, Mosquera JA, Vela P, Tornero J, Sánchez-Fernández S, Corominas H, Ramírez J, Avila G, Alonso A, Tortosa R, López-Lasanta M, Cañete JD, Marsal S. Julià A, et al. Among authors: montilla c. Pharmacogenomics. 2014 Nov;15(14):1763-1769. doi: 10.2217/pgs.14.125. Pharmacogenomics. 2014. PMID: 25493569
81 results